Neuroprotection by dehydroepiandrosteronesulfate: Role of an NF≃B-like factor

NeuroReport

Volumn 9, Issue 4, 1998, Pages 759-763

  Mao, Xianrong ^a   Barger, Steven W ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Cell culture; DHEA; Excitotoxicity; Hippocampus; NF B

Indexed keywords

GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; PRASTERONE; PRASTERONE SULFATE; CYCLOHEXIMIDE; NUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TRANSCRIPTION FACTOR;

AGING; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTROPHORETIC MOBILITY; EMBRYO; GENETIC TRANSCRIPTION; HIPPOCAMPUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; METABOLISM; NEOCORTEX; NERVE CELL; PHYSIOLOGY;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXIMIDE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; EMBRYO; GLUTAMIC ACID; HIPPOCAMPUS; NEOCORTEX; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RATS; THIONUCLEOTIDES; TRANSCRIPTION FACTORS;

EID: 0032498644     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199803090-00036     Document Type: Article

References (25)

1. Bellino FL. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Sciences, 1995.
2. Yoo A, Harris J and Dubrovsky B. Exp Neurol 137, 151-156 (1996).
3. Bologa L, Sharma J and Roberts E. J Neurosci Res 17, 225-234 (1987).
4. Browne ES, Porter JR and Correa G et al. J Steroid Biochem Mol Biol 45, 517-524 (1993).
5. Sapolsky RM. Science 273, 749-750 (1996).
6. Barger SW, Hörster D and Furukawa K et al. Proc Natl Acad Sci USA 92, 9328-9332 (1995).
7. Barger SW and Mattson MP. Mol Brain Res 40, 116-126 (1996).
8. Barger SW. Tumor necrosis factor: the good, the bad, and the umbra. In: Mattson MP, ed. Neuroprotective Signal Transduction. Totawa, NJ: Humana Press, 1997: 163-183.
9. Mattson MP, Barger SW and Begley J et al. Methods Cell Biol 46, 187-216 (1995).
10. Barger SW and Harmon AD. Nature 388, 878-881 (1997).
11. Dubinsky JM, Kristal BS and Elizondo-Fournier M. Neuropharmacology 34, 701-711 (1995).
12. Sunderland T, Merril CR, Harrington MG et al. Lancet ii, 570 (1989).
13. Demirgören S, Majewska MD, Spivak CE et al. Neuroscience 45, 127-135 (1991).
14. Monnet FP, Mahé V, Robel P et al. Proc Natl Acad Sci USA 92, 3774-3778 (1995).
15. Muir JK, Lobner D, Monyer H et al. J Cerebr Blood Flow Metab 16, 1211-1218 (1996).
16. Maurice T and Lockhart BP. Prog Neuropsychopharmacol Biol Psychiatry 21, 69-102 (1997).
17. Daynes RA, Araneo BA, Hennebold J et al. J Invest Dermatol 106 (Suppl), 14S-19S (1995).
18. Mohan PF and Jacobson MS. Am J Med Sci 306, 10-15 (1993).
19. McLachlan JA, Serkin CD and Bakouche O. J Immunol 156, 328-335 (1996).
20. Beg AA and Baltimore D. Science 274, 782-784 (1996).
21. Van Antwerp DJ, Martin SJ, Kafri T et al. Science 274, 787-789 (1996).
22. Wang CY, Mayo MW and Baldwin ASJ. Science 274, 784-787 (1996).
23. Guerrini L, Blasi F and Denis-Donini S. Proc Natl Acad Sci USA 92, 1510 (1995).
24. Kaltschmidt C, Kaltschmidt B and Baeuerle PA. Proc Natl Acad Sci USA 92, 9618-9622 (1995).
25. Keller JN, Kindy MS, Holtsberg FW et al. J Neurosci 18, 687-697 (1998).